0.01
+0(+0.00%)
Currency In USD
| Previous Close | 0.01 |
| Open | 0.01 |
| Day High | 0.01 |
| Day Low | 0.01 |
| 52-Week High | 0.31 |
| 52-Week Low | 0 |
| Volume | 35 |
| Average Volume | 56,327 |
| Market Cap | 168,273 |
| PE | -0.2 |
| EPS | -0.03 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.06 |
| Change | 0 |
If you invested $1000 in T2 Biosystems, Inc. (TTOO) 10 years ago, it would be worth $0 as of January 14, 2026 at a share price of $0.006. Whereas If you bought $1000 worth of T2 Biosystems, Inc. (TTOO) shares 5 years ago, it would be worth $0 as of January 14, 2026 at a share price of $0.006.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire Inc.
Jan 07, 2025 2:00 PM GMT
Achieved record fourth quarter and full-year 2024 sepsis product revenuesLEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibio
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
GlobeNewswire Inc.
Dec 18, 2024 2:00 PM GMT
Multiple instrument sale demonstrates growing market penetration of T2 Biosystems’ sepsis testsLEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and a
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
GlobeNewswire Inc.
Dec 17, 2024 2:00 PM GMT
Milestone demonstrates the growing customer adoption of the Company’s proprietary technologyLEXINGTON, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and anti
Data not available